Cancer Research
ISB 1442 Trial for Relapsed Multiple Myeloma Terminated Early
A first-in-human Phase 1/2 trial of ISB 1442 in relapsed/refractory multiple myeloma was halted before completion.
Clinical Trial
Jun 9, 2026 0
All Articles
609 articles
Cancer Research
CD226 Immune Receptor Explored as Predictor of Immunotherapy Response in Advanced Liver Cancer
A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.
Clinical Trial
Jun 9, 2026 0
Cancer Research
Metronomic Vinorelbine Plus Atezolizumab Tested as Second-Line NSCLC Therapy
A completed Phase 2 trial explores whether low-dose continuous chemotherapy can boost immunotherapy efficacy in advanced lung cancer.
Clinical Trial
Jun 9, 2026 0
Brain Health
Music Therapy and Robotics Team Up to Protect Aging Brains
A 210-person trial tests whether 5-month music therapy programs — and robotic assistants — can slow cognitive decline in older adults.
Clinical Trial
Jun 9, 2026 0
Heart Health
Semaglutide Tested Against Heart Failure and Obesity in Major Phase 3 Trial
A completed Phase 3 RCT examines whether weekly semaglutide injections improve symptoms and body weight in heart failure patients with obesity.
Clinical Trial
Jun 8, 2026 0
Heart Health
Pfizer's PCSK9 Inhibitor Bococizumab Put to the Test in High-Risk Hyperlipidemia
A Phase 3 trial examines whether bococizumab slashes LDL in statin-treated patients at elevated cardiovascular risk.
Clinical Trial
Jun 8, 2026 0
Regenerative Medicine
Biodegradable Temporizing Matrix Shows Promise for Deep Burn Wound Healing
A completed multicenter feasibility trial evaluates BTM, a novel biodegradable scaffold, for treating serious deep burn injuries.
Clinical Trial
Jun 8, 2026 0
Autoimmune & Arthritis
Large Phase 3 Trial Tests Rotavirus Vaccine Safety and Efficacy in 60,000 Infants
GSK's HRV vaccine faces its biggest test yet — can it prevent severe rotavirus gastroenteritis without raising intussusception risk?
Clinical Trial
Jun 8, 2026 0
Heart Health
Chinese PCSK9 Inhibitor Trial Tests IBI306 for High-Risk Cholesterol Patients
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
Clinical Trial
Jun 7, 2026 0
Hormones
NIH Study Uncovers How GnRH Deficiency Disrupts Puberty and Fertility
NIEHS researchers investigated how low or absent GnRH affects puberty, reproductive hormones, and fertility in adolescents and adults.
Clinical Trial
Jun 7, 2026 0
Gut & Microbiome
Probiotic LP-LDL Tested to Cut Cholesterol in Celiac Disease Patients
A completed pilot trial explores whether a cholesterol-lowering probiotic can improve cardiometabolic health in people with celiac disease.
Clinical Trial
Jun 6, 2026 0
Cancer Research
Combo Immunotherapy Plus Liver Embolization Targets Metastatic Uveal Melanoma
A phase II trial tests ipilimumab and nivolumab paired with immunoembolization against liver-spread uveal melanoma.
Clinical Trial
Jun 6, 2026 0